Stay updated on KarXT Long-Term Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.

Latest updates to the KarXT Long-Term Safety in Schizophrenia Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedSchizophrenia and related topics (MedlinePlus Genetics) were removed from the page.SummaryDifference0.1%

- Check15 days agoChange DetectedLocation sections and site names were added and several existing site entries were removed, altering the list of study sites available for participation.SummaryDifference1%

- Check23 days agoChange DetectedRemoved related topics 'Schizophrenia' and 'MedlinePlus Genetics' from the page's related topics section.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded related topic links: Schizophrenia and MedlinePlus Genetics to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision: v3.3.2 appears on the page and v3.2.0 is removed, indicating a minor version update. Core study content, endpoints, eligibility, and results remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page no longer displays the government funding notice and related topic links (Schizophrenia; MedlinePlus Genetics) that were present previously. These changes remove metadata/navigation items without affecting the core study details.SummaryDifference0.4%

Stay in the know with updates to KarXT Long-Term Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.